Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Willey

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
Advances in Radiation Oncology|March 5, 2021
Control and Toxicity in Melanoma Versus Other Brain Metastases in Response to Combined Radiosurgery and PD-(L)1 Immune Checkpoint InhibitionRoman L Travis, Samuel R Marcrom, Matthew H Brown, et al.
Practical Radiation Oncology|February 26, 2021
Transition From Manual to Automated Planning and Delivery of Volumetric Modulated Arc Therapy Stereotactic Radiosurgery: Clinical, Dosimetric, and Quality Assurance ResultsRichard A Popple, Matthew H Brown, Evan M Thomas, et al.
Plos One|January 14, 2012
Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific mannerChristine W Duarte, Christopher D Willey, Degui Zhi, et al.
Oncotarget|April 21, 2017
Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targetsEddy S Yang, Christopher D Willey, Amitkumar Mehta, et al.
Clinical and Translational Radiation Oncology|October 6, 2025
No differences in therapeutic efficacy while sparing healthy tissue for orthotopic glioblastoma patient-derived xenografts in context of proton FLASHTaylor L Schanel, Manoj Kumar, Lauren C Nassour-Caswell, et al.
Plos One|February 19, 2020
Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancerSindhu Nair, Hoa Q Trummell, Rajani Rajbhandari, et al.
Oncology Letters|April 30, 2017
MARCKS phosphorylation is modulated by a peptide mimetic of MARCKS effector domain leading to increased radiation sensitivity in lung cancer cell linesTimothy D Rohrbach, Robert B Jones, Patricia H Hicks, et al.
Frontiers in Genetics|November 2, 2020
Combining PARP and DNA-PK Inhibitors With Irradiation Inhibits HPV-Negative Head and Neck Cancer Squamous Carcinoma GrowthLing Zeng, Drexell Hunter Boggs, Chuan Xing, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2014
Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolinesJoshua C Anderson, Christine W Duarte, Karim Welaya, et al.
International Journal of Radiation Oncology, Biology, Physics|February 10, 2007
A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patientsChristopher D Willey, Barbara A Murphy, James L Netterville, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
Advances in Radiation Oncology|March 5, 2021
Control and Toxicity in Melanoma Versus Other Brain Metastases in Response to Combined Radiosurgery and PD-(L)1 Immune Checkpoint InhibitionRoman L Travis, Samuel R Marcrom, Matthew H Brown, et al.
Practical Radiation Oncology|February 26, 2021
Transition From Manual to Automated Planning and Delivery of Volumetric Modulated Arc Therapy Stereotactic Radiosurgery: Clinical, Dosimetric, and Quality Assurance ResultsRichard A Popple, Matthew H Brown, Evan M Thomas, et al.
Plos One|January 14, 2012
Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific mannerChristine W Duarte, Christopher D Willey, Degui Zhi, et al.
Oncotarget|April 21, 2017
Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targetsEddy S Yang, Christopher D Willey, Amitkumar Mehta, et al.
Clinical and Translational Radiation Oncology|October 6, 2025
No differences in therapeutic efficacy while sparing healthy tissue for orthotopic glioblastoma patient-derived xenografts in context of proton FLASHTaylor L Schanel, Manoj Kumar, Lauren C Nassour-Caswell, et al.
Plos One|February 19, 2020
Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancerSindhu Nair, Hoa Q Trummell, Rajani Rajbhandari, et al.
Oncology Letters|April 30, 2017
MARCKS phosphorylation is modulated by a peptide mimetic of MARCKS effector domain leading to increased radiation sensitivity in lung cancer cell linesTimothy D Rohrbach, Robert B Jones, Patricia H Hicks, et al.
Frontiers in Genetics|November 2, 2020
Combining PARP and DNA-PK Inhibitors With Irradiation Inhibits HPV-Negative Head and Neck Cancer Squamous Carcinoma GrowthLing Zeng, Drexell Hunter Boggs, Chuan Xing, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2014
Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolinesJoshua C Anderson, Christine W Duarte, Karim Welaya, et al.
International Journal of Radiation Oncology, Biology, Physics|February 10, 2007
A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patientsChristopher D Willey, Barbara A Murphy, James L Netterville, et al.
Pageof 15